Development of a standardized definition for clinically significant bleeding in the ASPirin in Reducing Events in the Elderly (ASPREE) trial

about

Development of a standardized definition for clinically significant bleeding in the ASPirin in Reducing Events in the Elderly (ASPREE) trial

Item

http://www.wikidata.org/entity/Q57179208

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Development of a standardized ...... in the Elderly (ASPREE) trial

@en

Development of a standardized ...... Reducing Events in the Elderly

@nl

type

Item

label

Development of a standardized ...... in the Elderly (ASPREE) trial

@en

Development of a standardized ...... Reducing Events in the Elderly

@nl

prefLabel

Development of a standardized ...... in the Elderly (ASPREE) trial

@en

Development of a standardized ...... Reducing Events in the Elderly

@nl

P1476

Development of a standardized ...... in the Elderly (ASPREE) trial

@en

P2093

Diane G Ives

http://www.w3.org/2001/XMLSchema#string

Erin C Schwartz

http://www.w3.org/2001/XMLSchema#string

Jessica Lockery

http://www.w3.org/2001/XMLSchema#string

Robyn L Woods

http://www.w3.org/2001/XMLSchema#string

Suzanne Satterfield

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

Final report on the aspirin component of the ongoing Physicians' Health Study

Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force.

Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force.

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.

Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.

P304

30-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CONCTC.2018.05.015

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

John J. McNeil

A R M Saifuddin Ekram

P577

2018-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30023457

http://www.w3.org/2001/XMLSchema#string

P921

aspirin

P932

6022241

http://www.w3.org/2001/XMLSchema#string